Petrelintide

Pipeline

Status by Indication[3][1]

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Impaired Renal Function1 trial

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function

Completed·Zealand Pharma·Phase 1·NCT07076030·39 enrolled

Overweight1 trial

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

Completed·Zealand Pharma·Phase 2·NCT06662539·493 enrolled

Concentration1 trial

Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations

Active, not recruiting·Zealand Pharma·Phase 1·NCT07338214·48 enrolled

Obesity or Overweight1 trial

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy and Safety of Petrelintide Co-Administered With RO7795068 in Adults With Obesity or Overweight

Not yet recruiting·Roche·Phase 2·NCT07589686·486 enrolled

Type 2 Diabetes1 trial

A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes

Completed·Zealand Pharma·Phase 2·NCT06926842·221 enrolled

1 more indication

Hepatic Function1 trial

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Hepatic Function

Recruiting·Zealand Pharma·Phase 1·NCT07682818·36 enrolled

Details

Drug Info

Related News